Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Rituximab (Rituxan) | American Journal of Neuroradiology
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis | Reumatología Clínica
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
B-Cell Targeted Therapies: Clinical Trials Update
Rheumatoid arthritis - The Lancet
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Rituximab-related Severe Toxicity | SpringerLink
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Rituximab - Wikipedia
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
